We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Fights Bid For Sanctions Over Remand Issue

Law360 (August 8, 2007, 12:00 AM EDT) -- Novartis has lashed out at a bid by two plaintiffs in the Aredia and Zometa litigation over their bid to sanction the pharmaceutical company for refusing to remand their cases to state court, arguing that recent case law warrants that the court deny the plaintiffs’ remand request.

The drug giant said in court documents filed Monday that recent New Jersey case law permitting a jury to determine whether a pharmaceutical manufacturer committed fraud to the U.S. Food and Drug Administration and thus may be liable for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.